Safety of Propofol Sedation ( > 200 mg) for Colonoscopy.
- Conditions
- Safety Issues
- Registration Number
- NCT05213208
- Lead Sponsor
- Showa Inan General Hospital
- Brief Summary
This study examines that the use of \>200 mg of propofol sedation enables patients to drive home safely after outpatient colonoscopy.
- Detailed Description
The hospital policy of routine discharge to normal activity 1 hour after propofol mono-sedation for EGD or colonoscopy was approved by the ethics committee of Showa Inan General Hospital in January, 2004 (http://www.sihp.jp). The investigator' s subsequent experience verified the safety of this discharge policy which was reconfirmed in March 2014. Based on these studies, the upper limit of 200 mg was established for those allowed early discharge and driving to home.
This study examines that the use of \>200 mg of propofol sedation enables patients to drive home safely 90-120 minutes after outpatient colonoscopy.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 300
- subjects who drive home by theirselves after colonoscopy using propofol sedation (>200 mg)
- Subjects who received emergency procedures
- less than 20 years old pregnant American Society of Anesthesiologists (ASA) class III or IV, overweight (body weight >100 kg) allergic to the drugs used or its components (soybeans or eggs).
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Traffic accidents 1 day Number of traffic accidents
- Secondary Outcome Measures
Name Time Method Patient satisfaction 1 day Patient satisfaction (bad, 0-good 100%) is asked.
Trial Locations
- Locations (1)
Showa Inan General hospital
🇯🇵Komagane, Nagano, Japan